Full Text View
Tabular View
No Study Results Posted
Related Studies
Use of Alfuzosin in Stone Treatment With ESWL
This study is currently recruiting participants.
Study NCT00388271   Information provided by Singapore General Hospital
First Received: October 13, 2006   Last Updated: October 3, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Urinary Calculi
Additional conditions recognized in this trial
Calculi
More general conditions related to this trial
Pathological Conditions, Anatomical
Urolithiasis
Urologic Diseases
Interventions listed in this trial
Alfuzosin (Xatral)
standard treatment
Additional drug interventions recognized in this trial
Adrenergic alpha-Antagonists
Alfuzosin
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Antagonists
Antihypertensive Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Singapore General Hospital
Sanofi-Synthelabo


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services